Treatment for Partners with Chlamydia
The recommended first-line treatment for a partner with chlamydia is doxycycline 100 mg orally twice daily for 7 days, which has superior efficacy (95.5% for urogenital infections and 96.9% for rectal infections) compared to alternative regimens. 1
Treatment Options
First-Line Treatment
Alternative Treatment Options
Azithromycin: 1 g orally in a single dose 1
Erythromycin options (for patients who cannot take doxycycline):
Partner Management Guidelines
- All sexual partners from the preceding 60 days should be evaluated, tested, and treated 1
- If the last sexual contact was more than 60 days before diagnosis, the most recent partner should still be treated 1
- Partners should abstain from sexual intercourse until:
- 7 days after completing single-dose therapy, OR
- Until completion of a 7-day regimen 1
Special Considerations
Co-infection with Gonorrhea
- Consider dual therapy with ceftriaxone 125 mg IM in a single dose PLUS azithromycin 1 g orally in a single dose OR doxycycline 100 mg orally twice daily for 7 days 1
- This approach addresses increasing resistance patterns and treats potential co-infections 1
Pregnancy
- Doxycycline is contraindicated during pregnancy 1
- Azithromycin or erythromycin should be used instead 1, 4
Maximizing Treatment Success
- Medications should be dispensed on-site when possible 1
- First dose should be directly observed to improve compliance 1
- Test of cure is generally not needed after completing treatment with doxycycline or azithromycin unless symptoms persist 1
- Test of cure should be considered 3 weeks after completion of treatment with erythromycin 1
Follow-up Recommendations
- Retesting is recommended approximately 3 months after treatment due to high risk of reinfection (up to 39% in some studies) 1
- Consistent and correct condom use is recommended to reduce reinfection risk 1
Common Pitfalls to Avoid
- Undertreating rectal infections: Azithromycin has significantly lower efficacy for rectal chlamydia (76.4%) compared to doxycycline (96.9%) 1, 3
- Failing to treat partners: High reinfection rates make partner treatment essential 1
- Inadequate follow-up: Retesting at 3 months is crucial due to high reinfection rates 1
- Missing co-infections: Patients with chlamydia often have concurrent gonorrhea requiring dual therapy 1